Cudetaxestat Did Not Interact with Ofev in Animal Study

Cudetaxestat Did Not Interact with Ofev in Animal Study

306658

Cudetaxestat Did Not Interact with Ofev in Animal Study

Cudetaxestat (BLD-0409), an investigational treatment for idiopathic pulmonary fibrosis (IPF) being developed by Blade Therapeutics, does not interact with the approved IPF treatment Ofev (nintedanib), according to research done in rats. “We believe that these are important data that help inform our step-wise approach to advance the clinical development program for cudetaxestat,” Wendye Robbins, MD, president and CEO of Blade, said in a press release. Cudetaxestat works by blocking the activity of autotaxin, an enzyme that…

You must be logged in to read/download the full post.